Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Evaluate the Effectiveness and Safety of CG5503 Extended Release (ER) in Patients With Moderate to Severe Chronic Low Back Pain
This study has been completed.
Study NCT00449176   Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received: March 16, 2007   Last Updated: March 19, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Low Back Pain
Additional conditions recognized in this trial
Back Pain
More general conditions related to this trial
Nervous System Diseases
Neurologic Manifestations
Pain
Signs and Symptoms
Interventions listed in this trial
CG5503
oxycodone
placebo
More general drug interventions related to this trial
Analgesics
Analgesics, Opioid
Central Nervous System Agents
Central Nervous System Depressants
Narcotics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Johnson &Johnson Pharmaceutical Research &Development, L.L.C.
Grünenthal GmbH


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services